Charles River Laboratories International, Inc. (CRL)
278.26
+5.26
(+1.93%)
USD |
NYSE |
Sep 11, 16:00
278.31
+0.05
(+0.02%)
Pre-Market: 20:00
Charles River Laboratories International Price to Book Value : 4.677 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 4.677 |
| September 10, 2026 | 4.588 |
| September 09, 2026 | 4.678 |
| September 08, 2026 | 4.719 |
| September 04, 2026 | 4.849 |
| September 03, 2026 | 4.931 |
| September 02, 2026 | 4.904 |
| September 01, 2026 | 4.746 |
| August 31, 2026 | 4.845 |
| August 28, 2026 | 4.900 |
| August 27, 2026 | 4.982 |
| August 26, 2026 | 4.96 |
| August 25, 2026 | 5.003 |
| August 24, 2026 | 5.018 |
| August 21, 2026 | 4.962 |
| August 20, 2026 | 4.899 |
| August 19, 2026 | 4.874 |
| August 18, 2026 | 4.693 |
| August 17, 2026 | 4.818 |
| August 14, 2026 | 4.707 |
| August 13, 2026 | 4.728 |
| August 12, 2026 | 4.780 |
| August 11, 2026 | 4.740 |
| August 10, 2026 | 4.656 |
| August 07, 2026 | 4.496 |
| Date | Value |
|---|---|
| August 06, 2026 | 4.463 |
| August 05, 2026 | 4.382 |
| August 04, 2026 | 3.935 |
| August 03, 2026 | 3.880 |
| July 31, 2026 | 3.908 |
| July 30, 2026 | 3.943 |
| July 29, 2026 | 3.946 |
| July 28, 2026 | 4.041 |
| July 27, 2026 | 3.77 |
| July 24, 2026 | 3.808 |
| July 23, 2026 | 3.854 |
| July 22, 2026 | 3.676 |
| July 21, 2026 | 3.688 |
| July 20, 2026 | 3.693 |
| July 17, 2026 | 3.771 |
| July 16, 2026 | 3.852 |
| July 15, 2026 | 3.836 |
| July 14, 2026 | 3.886 |
| July 13, 2026 | 3.862 |
| July 10, 2026 | 3.923 |
| July 09, 2026 | 3.926 |
| July 08, 2026 | 3.764 |
| July 07, 2026 | 3.844 |
| July 06, 2026 | 3.890 |
| July 02, 2026 | 3.877 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| IQVIA Holdings, Inc. | 6.982 |
| Medpace Holdings, Inc. | 37.70 |
| Fortrea Holdings, Inc. | 3.120 |
| Champions Oncology, Inc. | 18.23 |
| Avantor, Inc. | 1.780 |
Price to Book Value Related Metrics
| PS Ratio | 3.403 |
| PEG Ratio | -0.2154 |
| Price to Free Cash Flow | 36.72 |
| Price | 278.26 |
| Earnings Yield | -1.74% |
| Market Cap | 13.28B |
| PEGY Ratio | -0.2154 |
| Operating PE Ratio | 25.18 |
| Normalized PE Ratio | 147.89 |